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Objective: The mortality of re-bleeding following aneurysmal subarachnoid hemorrhage is
high, and surviving patients often have poor clinical condition and worse outcome than
patients with a single bleed. In this study, we performed an updated systematic review and
meta-analysis to determine the most common risk factors for re-bleeding in this patient
population, with the goal of providing neurologists, neurosurgeons, neuro-interventional-
ists with a simple and fast method to evaluate the re-bleeding risk for aneurysmal sub-
arachnoid hemorrhage.
Method: We conducted a thorough meta-analysis of the risk factors associated with re-
bleeding or re-rupture of intracranial aneurysms in cases published between 2000 and 2013.
Pooled mean difference was calculated for the continuous variables (age), and pooled odds
ratio (OR) was calculated for categorical factors. If heterogeneity was signiﬁcant ( p < 0.05), a
random effect model was applied; otherwise, a ﬁxed model was used. Testing for pooled
effects and statistical signiﬁcance for each potential risk factor were analyzed using Review
Manager software.
Results: Our literature search identiﬁed 174 articles. Of these, only seven retrospective studies
met the inclusion criteria. These seven studies consisted of 2470 patients, 283 of which had
aneurysmal re-bleeding, resulting in a weighted average rate of re-bleeding of 11.3% with 95%
conﬁdence interval [CI]: 10.1–12.6. In this population, sex (OR 1.46; 95% CI: 1.11–1.92), high
systolic blood pressure [SBP] (OR 2.52; 95% CI: 1.40–4.53), aneurysm size (OR 3.00; 95% CI: 2.06–
4.37), clinical condition (Hunt & Hess) (OR 4.94; 95% CI: 2.29,10.68), and Fisher grade (OR 2.29;
95% CI: 1.45, 3.61) were statistically signiﬁcant risk factors for re-bleeding.
Conclusion: Sex, high SBP, high Fisher grade, aneurysm size larger than 10 mm, and poor
clinical condition were independent risk factors for aneurysmal re-bleeding. The importance
of early aneurysm intervention and careful consideration of patient risk factors should be
emphasized to eliminate the risk of re-bleeding and poor outcome.
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1. Introduction
10–15% of patients with aneurysmal subarachnoid hemor-
1. Studies pertaining to patients with SAH due to aneurysmal
re-rupture after previous bleeding, as demonstrated by
neuroimaging such as magnetic resonance image (MRI),
computed tomography angiography (CTA), digital subtrac-
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die within the ﬁrst 24 h of SAH, and by the 30th day following
SAH, the overall case fatality rate increases to nearly 50% [1,2].
25–30% of survivors re-bleed within the ﬁrst four weeks
following the initial SAH [5]. After the ﬁrst six weeks following
SAH, the re-bleeding rate drops to about 4% per year, and 50–
90% of re-bleeding episodes occur in the ﬁrst 6 h after the
primary bleed [3,4]. Patients who experience re-bleeding have
especially high mortality, reportedly as high as 75–80% [5–8].
Risk of re-bleeding is high if the aneurysm is left untreated,
and 25% of patients die as a result of medical complications of
SAH [9], such as neurogenic pulmonary edema and neurogenic
stunned myocardium. For these reasons, early detection and
accurate evaluation of the incidence of and predictors for re-
bleeding are critical, as risk factors associated with aneurysm
re-bleeding are still controversial. Moreover, re-bleeding can
occur before patients are admitted or during transfer to the
hospital [10,11] or after hospitalization.
In this study, we analyzed potential risk factors for
aneurysmal re-bleeding among patient information that is
available after admission to the hospital. We reviewed 9
factors that may have signiﬁcant impact on the likelihood of
re-rupture after primary bleeding. These ﬁndings will assist
neurologists, neurosurgeons, and health care providers in
optimizing patient outcome by informing them of the most
common risk factors of re-bleeding in subarachnoid hemor-
rhage patients.
2. Materials and methods
2.1. Literature search and selection of relevant studies
We conducted a careful meta-analysis of data from all
publications between 2000 and 2013 pertaining to the risk of
re-bleeding or re-rupture of intracranial aneurysms. Relevant
literature was identiﬁed by a MEDLINE, EMBASE, COCHRANE,
Web of Science search using the following keywords in
different combinations: cerebral aneurysms, intracranial
aneurysms, re-bleeding, re-rupture, recurrent hemorrhage,
risk factors. Additionally, we searched the reference lists of
articles identiﬁed in our initial search for other relevant
publications, as well as the references found in articles
identiﬁed in this secondary search. Quality control of the
selected studies was performed using the Newcastle-Ottawa
Scale (NOS, Ottawa Hospital Research Institute), which was
collaboratively developed by the University of Newcastle and
University of Ottawa as a means of evaluating the reliability
and validity of non-randomized studies. It uses the means of
study group selection, comparability of those groups, and how
the outcome or exposure was determined to assign a reliability
score to the study in question.
2.1.1. Inclusion criteria
Studies meeting the following criteria were included in our
analysis:tion angiography (DSA).
2. Studies comparing multiple risk factors in re-bleeding and
non-re-bleeding groups such as: sex, age, clinical conditions
at admission (assessed by Hunt & Hess scale), hypertension,
location of aneurysm, presence of multiple aneurysms, size
of aneurysm, Fisher grade, external ventricle drainage
(EVD).
2.1.2. Exclusion criteria
Studies meeting the following criteria were excluded from our
analysis:
1. Studies with fewer than 20 patients, as smaller studies are
more likely to suffer from selection bias.
2. Studies where multiple reports were published for the same
study population.
3. Studies reported as a review, case report, or editorial.
4. Studies of SAH due to non-aneurysmal pathology (i.e.
trauma, arteriovenous malformation (AVM), etc.).
5. Studies reported in languages other than English.
2.2. Data extraction
Two reviewers independently extracted data on patient and
aneurysm characteristics and pre-operative treatment from
all studies that met the inclusion criteria. In the event of
disagreement between the 2 reviewers regarding whether a
study met inclusion criteria, consensus was reached by joint
review.
2.3. Index of measurements
We extracted data on age, sex, hypertension, aneurysm
location, multiple aneurysms, size, clinical condition (Hunt &
Hess), Fisher grade, and external ventricle drainage (EVD)
wherever possible. With the exception of age, which was
evaluated as a continuous variable, each factor was classiﬁed
into one of the two categories, as follows: sex (male or
female), hypertension (>160 mmHg), aneurysm location
(anterior or posterior circulation, see below), multiple
aneurysms (yes or no), size (≥10 mm or <10 mm), clinical
condition (good, I–II–III on Hunt & Hess scale, or poor, IV–V on
Hunt & Hess scale), Fisher grade (≥3 or <3), and EVD (yes or
no). The location of the aneurysms was classiﬁed as either (1)
anterior circulation: anterior communicating artery, internal
carotid artery, anterior cerebral artery, middle cerebral
artery, posterior communicating artery, or (2) posterior
circulation: vertebral artery, basilar artery, posterior cerebral
artery.
2.4. Data analysis
1. Data (9 factors) were extracted from the 7 studies that met
inclusion criteria and entered into a spreadsheet in
Microsoft Excel software.
68 records for eligibility
7 studies included in the meta-
analysis
106 studies excluded because of
duplicates, reviews, comments,
case reports, non-English articles.
61 articles did not describe factors
that affect aneurysmal re-bleeding
174 articles were identified
through database searching
Fig. 1 – Flow chart for identifying articles to be included in the meta-analysis.
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Cochrane Centre) was used to ﬁnd pooled effects and
perform signiﬁcance testing for each potential risk factor.
RevMan is available free of charge for academic use at the
Cochrane Informatics and Knowledge Management Depart-
ment website.
3. Pooled mean difference was calculated for the continuous
variables (age), and pooled odds ratio was calculated for
categorical factors.
4. For risk factors with signiﬁcant ( p < 0.05) heterogeneity, a
random effect model was applied. For risk factors without
signiﬁcant heterogeneity, a ﬁxed model was used.Table 1 – Overview of the 7 included studies.
Author Publication
year
Number of
patients
Re-bleeding
rate
Study p
(yea
Total Re-
bleed
No-re-
bleed
Cha
et al. [22]
2010 492 38 454 8.4% 12 (1995–
Beck
et al. [28]
2006 237 23 214 10.7% 3 (1999–
Guo
et al. [23]
2013 326 70 256 27.3% 9.3 (2002
Cong
et al. [14]
2012 458 63 395 15.9% 3 (2005–
Naidech
et al. [13]
2005 574 40 534 7.5% 6 (1996–
Ohkuma
et al. [4]
2001 273 37 236 15.7% 10 (1989–
Wu
et al. [30]
2012 110 12 98 12.2% 3 (2007–
Total 2470 2833. Results
3.1. Literature search and study selection
Our literature search identiﬁed 174 articles. Of those, only
seven retrospective studies met the inclusion criteria (Fig. 1).
Those seven studies included 2470 patients, 283 of which had
aneurysmal re-bleeding (Table 1). To control for the quality of
the studies we selected for further analysis, we performed a
quality evaluation of each study using the Newcastle-Ottawa
Scale (NOS). Each study included in our analysis rated aboveeriod
r)
Study
design
Diagnosis of
re-bleeding
Journal Details of
patient
selection
provided
2007) Retrospective CT J Korean
Neurosurg Soc
No
2002) Retrospective CT Stroke No
–2010) Retrospective CT or lumbar
puncture
World
Neurosurg
No
2008) Retrospective CT Turkish
Neurosurgery
Yes
2002) Retrospective CT Arch Neurol Yes
1998) Retrospective CT Stroke Yes
2010) Retrospective CT J Comput
Assist Tomogr
Yes
Table 2 – Risk factors investigated and quality evaluation
for each included study.
Authors Risk factors
investigated
Score,
NOS scale
Cha et al. A B C D E F G H 7
Beck et al. A B F H I 8
Guo et al. A B C D F G H 8
Cong et al. A B C D E G 8
Naidech et al. G I 8
Ohkuma et al. A B C D G 7
Wu et al. A B C D F H 7
A: Age, B: Sex, C: High SBP, D: aneurysm location, E: multiple
aneurysms, F: aneurysm size, G: Hunt & Hess grade, H: Fisher
grade, I: EVD.
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of data was collected (Table 2). In these seven studies, the
weighted average rate of re-bleeding was 11.3% with 95%
conﬁdence interval [CI]: 10.1–12.6.
3.2. Meta-analysis
We performed a meta-analysis of the data presented in the
seven selected studies to evaluate the likelihood of nine
different factors to correlate with increased risk of aneu-
rysm re-bleeding. Of those nine factors, sex (males are at
greater risk than females) (OR 1.46; 95% conﬁdence interval
[CI]: 1.11, 1.92), high systolic blood pressure [SBP] (OR 2.52;
95% CI: 1.40, 4.53), aneurysm size (greater than 10 mm) (OR
3.00; 95% CI: 2.06–4.37), poor clinical condition (as deﬁned by
Hunt & Hess) (OR 4.94; 95% CI: 2.29–10.68), and high Fisher
grade (OR 2.29; 95% CI: 1.45–3.61) were associated with
signiﬁcantly increased odds of re-bleeding. In contrast, age
(OR 1.72;95% CI:1.61–5.04), aneurysm location (OR 1.59;
95% CI: 0.72–3.48), presence of multiple aneurysms (OR 1.11;
95% CI: 0.58–2.09), and EVD (OR 2.96; 95% CI: 0.86–10.22)
were not signiﬁcant risk factors for re-bleeding in aneurys-
mal SAH patients according to our analysis (Table 3 and
Figs. 2–10).Table 3 – Meta-analysis.
Risk factor Number
of studies
Heterogeneity
Chi-squared m
p I2 (%)
Age (mean) 6 0.009 67 
Sex
Male vs. female
6 0.61 0 
Hypertension 4 0.01 72 
Location anterior circulation vs.
posterior circulation
5 0.83 0 
Multiple aneurysms 2 0.12 58 
Size ≥10 mm vs. <10 mm 4 0.11 50 
Hunt & Hess grade IV–V vs. I–II–III 5 0.0001 83 
Fisher grade ≥3 vs. <3 4 0.34 11 
External ventricular drainage (EVD) 2 0.03 78 4. Discussion
The cases studied in this report had a re-bleeding incidence of
7.5–27.3%, with a weighted average rate of re-bleeding of 11.3%
with 95% conﬁdence interval [CI]: (10.1, 12.6)%.
4.1. Age and sex
Previous reports indicate that patients of advanced age have
poor outcome after SAH [12], and several studies have reported
that older people have a higher tendency to re-bleed than
control cases [12]. However, studies by Naidech et al. and Cong
et al. suggested that age was not associated with re-bleeding
[13,14]. Our meta-analysis of patient data published since 2000
did not ﬁnd signiﬁcant differences between the ages of
patients who did and did not experience re-bleeding following
SAH (Fig. 2).
Our analysis indicated that males had a signiﬁcantly higher
risk of re-bleeding than females, in contrast to previous data
suggesting that female patients have particularly high risk [15]
(Fig. 3). In part, this may be due to a greater prevalence of
smoking in male patients, as smoking can lead to damage of
the cerebral vessels and increase the risk of SAH recurrence.
4.2. Hunt & Hess grade
Generally, a patient's clinical and neurological condition at
admission is evaluated by the Hunt & Hess grading system [16].
Several studies reported that poor condition at admission, as
indicated by a high Hunt & Hess grade, was associated with
aneurysmal re-bleeding [4,5,13,17–19]. Our analysis supports
these studies, which showed that SAH patients who initially
presented with high Hunt & Hess grades (IV–V), indicative of
poor clinical condition, have greater likelihood of re-bleeding
than those with low Hunt & Hess grades (I–III) (Fig. 4). Though
one study in our analysis, by Inagawa et al., did not ﬁnd a
relationship between poor patient condition and re-bleeding
[20], this may be a result of the frequent necessity to intubate
and sedate patients with higher Hunt & Hess scores, making
clinical diagnosis difﬁcult.Models of
eta-analysis
Pooled OR/
odd ratio
95% CI Z p
Random 1.72 1.61 to 5.04 1.01 0.31
Fixed 1.46 1.11–1.92 2.71 0.007
Random 2.52 1.40–4.53 3.08 0.002
Random 1.59 0.72–3.48 1.15 0.25
Fixed 1.11 0.58–2.09 0.31 0.76
Fixed 3.00 2.06–4.37 5.74 0.00001
Random 4.94 2.29–10.68 4.07 <0.0001
Fixed 2.29 1.45–3.61 3.55 0.0004
Random 2.96 0.86–10.22 1.72 0.09
There are 6 studies describing sex and re-bleeding. Pooled effects: OR (95% CI): 1.46
(1.11,1.92).
Study or Subgroup
Cha 2010
Beck 2006
Guo 2013
Cong 2012
Naidech 2005
Ohkuma 2001
Wu 2012
Total (95% CI)
Total events
Heterogeneity: Chi² = 3.60, df = 5 (P = 0.61); I² = 0%
Test for overall effect: Z = 2.71 (P = 0.007)
Events
21
11
31
32
0
17
6
118
Total
38
23
70
63
0
37
12
243
Events
161
87
99
147
0
73
33
600
Total
454
214
256
395
0
163
65
1547
M-H, Fixed, 95% CI
2.25 [1.15, 4.38]
1.34 [0.56, 3.17]
1.26 [0.74, 2.15]
1.74 [1.02, 2.97]
Not estimable
1.05 [0.51, 2.15]
0.97 [0.28, 3.32]
1.46 [1.11, 1.92]
Rebleeding No -rebleeding Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.2 0.5 1 2 5
Female Male
Fig. 3 – Meta-analysis of re-bleeding and sex.
There are 6 studies describing age and re-bleeding. Pooled effects: OR (95% CI): 1.72
(-1.61,5.04).
Study or Subgroup
Cha 2010
Beck 2006
Guo 2013
Cong 2012
Naidech 2005
Ohkuma 2001
Wu 2012
Total (95% CI)
Heterogeneity: Tau² = 10.43; Chi² = 15.33, df = 5 (P = 0.009); I² = 67%
Test for overall effect: Z = 1.01 (P = 0.31)
Mean
51.7
52
58.2
55
0
61.2
57
SD
11.22
15.8
8.99
20
0
12.1
18
Total
38
23
70
63
0
37
12
243
Mean
53.69
53.6
52.07
53
0
58.6
56.5
SD
12.06
13.7
10.15
17
0
12.3
15.6
Total
454
214
256
395
0
236
98
1653
IV, Random, 95% CI
-1.99 [-5.73, 1.75]
-1.60 [-8.31, 5.11]
6.13 [3.68, 8.58]
2.00 [-3.22, 7.22]
Not estimable
2.60 [-1.60, 6.80]
0.50 [-10.14, 11.14]
1.72 [ -1.61, 5.04]
Rebleed No -rebleeding Mean Difference Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Bleeding patient Young Bleeding patient Old
Fig. 2 – Meta-analysis of re-bleeding and age.
There are 5 studies describing Hunt & Hess  and re-bleeding. Pooled effects: OR 
(95% CI):4.94(2.29,10.68).
Study or Subgroup
Cha 2010
Beck 2006
Guo 2013
Cong 2012
Naidech 2005
Ohkuma 2001
Wu 2012
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.63; Chi² = 23.51, df = 4 (P = 0.0001); I² = 83%
Test for overall effect: Z = 4.07 (P < 0.0001)
Events
33
0
31
12
26
24
0
126
Total
38
0
70
63
40
37
0
248
Events
123
0
65
46
133
40
0
407
Total
454
0
256
395
532
236
0
1873
M-H, Random, 95% CI
17.76 [6.78, 46.53]
Not estimable
2.34 [1.35, 4.05]
1.79 [0.89, 3.59]
5.57 [2.83, 10.98]
9.05 [4.25, 19.26]
Not estimable
4.94 [2.29, 10.68]
Rebleeding No -rebleeding Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.05 0.2 1 5 20
Score <=III Score >III
Fig. 4 – Meta-analysis of re-bleeding and hypertension.
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There are 4 studies describing hypertension and re-bleeding. Pooled effects: OR 
(95% CI): 2.52 (1.40,4.53).
Study or Subgroup
Cha 2010
Beck 2006
Guo 2013
Cong 2012
Naidech 2005
Ohkuma 2001
Wu 2012
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.26; Chi² = 10.70, df = 3 (P = 0.01); I² = 72%
Test for overall effect: Z = 3.08 (P = 0.002)
Events
16
0
44
32
0
26
0
118
Total
38
0
70
63
0
37
0
208
Events
159
0
65
142
0
100
0
466
Total
454
0
256
395
0
236
0
1341
M-H, Random, 95% CI
1.35 [0.69, 2.64]
Not estimable
4.97 [2.84, 8.71]
1.84 [1.08, 3.14]
Not estimable
3.21 [1.52, 6.81]
Not estimable
2.52 [1.40, 4.53]
Rebleeing No -rebleeding Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.1 0.2 0.5 1 2 5 10
No Hypertension hypertension
Fig. 5 – Meta-analysis of re-bleeding and aneurysm location.
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Prior to this study, published data have not reached a
consensus on the role that high systolic blood pressure plays
in risk of aneurysmal re-bleeding following SAH. Naidech et al.
found that hypertension is not associated with re-bleeding
after SAH [13], and a second, large study reported a re-bleeding
rate of 6.9% after admission to the hospital, but did not ﬁnd a
relationship between blood pressure and likelihood of re-
bleeding [21]. In contrast, many other studies found that high
blood pressure following initial SAH can lead to an increased
risk of re-bleeding [4,17,22,23]. In particular, Ohkuma et al.
found that re-bleeding is more common in patients with high
systolic blood pressure (above 160 mmHg) [4]. Our pooled
analysis of multiple studies demonstrated that high systolic
blood pressure (above 160 mmHg) is a major risk factor for
aneurysmal re-bleeding in SAH patients (Fig. 5).
4.4. Fisher grade
The appearance of SAH by CT scan is classiﬁed by Fisher grade
of 1–4, with 4 being the worst. Patients with intracerebral orThere are 4 studies describing Fisher Grade an
(95% CI):2.29(1.45,3.61).
Study or Subgroup
Cha 2010
Beck 2006
Guo 2013
Cong 2012
Naidech 2005
Ohkuma 2001
Wu 2012
Total (95% CI)
Total events
Heterogeneity: Chi² = 3.37, df = 3 (P = 0.34); I² = 11%
Test for overall effect: Z = 3.55 (P = 0.0004)
Events
36
20
47
0
0
0
11
114
Total
38
23
70
0
0
0
12
143
Events
329
160
140
0
0
0
80
709
Total
454
211
256
0
0
0
98
1019
Rebleeding No- rebleeding
Fig. 6 – Meta-analysis of re-bleedintraventricular hematoma usually present with poor clinical
condition (high Hunt & Hess grade) and high blood pressure.
Previous studies suggest that this may lead to early re-rupture
of the aneurysm. For example, Reynold et al. reported higher
incidence of intracerebral hematoma in patients with signs of
repeated aneurysm rupture [24], which may, in turn, substan-
tially contribute to the poor clinical condition of patients with
repeated SAH. However, in contrast to our analysis, which
indicates that Fisher grade is a signiﬁcant risk factor for re-
bleeding (Fig. 6), studies by Inagawa et al. and Guo et al. did not
ﬁnd any correlation between Fisher grade and re-bleeding
[20,23].
4.5. External ventricular drainage (EVD)
Acute hydrocephalus is a common complication after aneu-
rysmal SAH. Treatment of acute hydrocephalus involves
emergent cerebral spinal ﬂuid (CSF) drainage, which often
results in improvement of the patient's clinical condition.
There are many conﬂicting studies that suggest CSF drainage
can lead to aneurysmal re-bleeding [13,25,26]. The most
accepted theory is that CSF drainage in patients with and re-bleeding. Pooled effects: OR 
M-H, Fixed, 95% CI
6.84 [1.62, 28.83]
2.13 [0.61, 7.44]
1.69 [0.97, 2.95]
Not estimable
Not estimable
Not estimable
2.48 [0.30, 20.41]
2.29 [1.45, 3.61]
Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.02 0.1 1 10 50
Fisher grade <3Fisher grade >=3
ing and multiple aneurysms.
There are 2 studies describing EVD and re-bleeding. Pooled effects: OR (95% CI): 2.96 
(0.86-10.22).
Study or Subgroup
Cha 2010
Beck 2006
Guo 2013
Cong 2012
Naidech 2005
Ohkuma 2001
Wu 2012
Total (95 % CI)
Total events
Heterogeneity: Tau² = 0.63; Chi² = 4.65, df = 1 (P = 0.03); I² = 78%
Test for overall effect: Z = 1.72 (P = 0.09)
Events
0
15
0
0
29
0
0
44
Total
0
23
0
0
40
0
0
63
Events
0
118
0
0
175
0
0
293
Total
0
214
0
0
534
0
0
748
M-H, Random, 95% CI
Not estimable
1.53 [0.62, 3.75]
Not estimable
Not estimable
5.41 [2.64, 11.08]
Not estimable
Not estimable
2.96 [0.86, 10.22]
Rebleeding No -rebleeding Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.02 0.1 1 10 50
Without drainage With drainage
Fig. 7 – Meta-analysis of re-bleeding and aneurysm size.
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mural pressure across the aneurysm wall, and this may lead to
increased likelihood of re-bleeding [27]. In spite of this, the
study performed by Beck et al. did not ﬁnd a strong correlation
between external ventricular drainage and re-bleeding [28].
Our analysis, which included the aforementioned Beck study
and one conducted by Naidech et al. [13] in which EVD was a
signiﬁcant risk factor for re-bleeding, did not indicate that,
when taken together, those two studies demonstrated a
signiﬁcant relationship between EVD and increased risk of
re-bleeding in aneurysmal SAH patients (Fig. 7).
4.6. Aneurysm location
Previous studies demonstrated that the location of an
aneurysm can have an effect on likelihood of re-bleeding
[3,28], especially in the anterior communicating artery
(AComA) and posterior communicating artery (PComA) [29].
A study by Cong W et al. indicated that patients with a
posterior circulation aneurysm have higher bleeding risk than
those with an aneurysm in the non-posterior circulation [14].
The present study reveals that, on aggregate, aneurysmStudy or Subgroup
Cha 2010
Beck 2006
Guo 2013
Cong 2012
Naidech 2005
Ohkuma 2001
Wu 2012
Total (95% CI)
Total events
Heterogeneity: Chi² = 0.89, df = 3 (P = 0.83); I² = 0%
Test for overall effect: Z = 1.15 (P = 0.25)
Events
38
0
66
46
0
35
11
196
Total
38
0
70
42
0
37
12
199
Events
438
0
230
359
0
225
87
1339
Total
454
0
256
315
0
236
98
1359
M-H, F
2.90 
N
1.87
N
N
0.86
1.39 
1.59
Experimental No -rebleeding Odd
There are 5 studies describing aneurysm location 
(95% CI): 1.59 (0.72,3.48).
Fig. 8 – Meta-analysis of re-bleedlocation was not a signiﬁcant risk factor for re-bleeding
(Fig. 8), in agreement with the conclusions drawn by studies
performed by Guo et al. and Wu et al. [23,30].
4.7. Aneurysm size
Most studies emphasize the importance of aneurysm size in
determining risk for initial rupture [31,32]. Guo et al. also found
that the probability of re-bleeding in patients with aneurysms
larger than 10 mm was 1.624-fold greater than those with
aneurysms of 10 mm or less [23], but other studies have not
conﬁrmed this association [17,22]. Our analysis demonstrated,
however, that large aneurysm size does confer signiﬁcant risk
of aneurysmal re-bleeding (Fig. 9).
4.8. Multiple aneurysms
Patients with several aneurysms often have more fragile
vessel walls that may be prone to aneurysm formation in
general or re-bleeding after the initial aneurysm rupture. In
spite of this, some studies have shown that there was no
signiﬁcant difference in likelihood of re-bleeding in patientsixed, 95% CI
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n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 3 4 6 – 3 5 5 353with multiple aneurysms [14]. Beck et al. did report an
increased risk of re-bleeding in patients with multiple
aneurysms patients [28]; however, our analysis indicated that
there is no signiﬁcant correlation between presence of
multiple aneurysms and re-bleeding (Fig. 10).
5. Conclusion
According to our meta-analysis of several published studies of
occurrence of re-bleeding in aneurysmal SAH patients, sex,
hypertension, patient condition, aneurysm size, and Fisher
grade are major risk factors in determining the likelihood a
patient will experience re-bleeding. In those same studies, no
correlation was found between age, EVD, aneurysm location,
and presence of multiple aneurysms and aneurysm re-
bleeding. Based on these results, we advocate early surgery
for primary ruptured aneurysm in patients with good clinical
condition to minimize the risk of re-bleeding. Furthermore,
maintenance of systemic blood pressure in a moderately
hypertensive range (140–160 mmHg) may help to prevent earlyre-rupture of the aneurysm. Notably, the studies evaluated
here assessed re-bleeding rates prior to treatment of the
SAH, and as such, the amount of time between the initial
onset of bleeding and treatment of the SAH can have an effect
on the likelihood of re-bleeding. Future studies that take this
factor into account will be critical to the follow-up of this
study.
6. Limitations of this study
All the studies examined here are retrospective, making data
quality difﬁcult to monitor. Only a few studies described clear
inclusion and exclusion criteria, and each study was con-
ducted with different study objectives. Diagnostic criteria
frequently vary from hospital to hospital, which could yield
some inconsistency in results. The risk factors studied differ
from study to study depending on the study focus. Lastly, a
larger sample size would improve the reliability of the
analysis. Due to limited availability of data for some risk
factors, we were only able to include information from two
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 3 4 6 – 3 5 5354independent studies, which decreases the strength of the
conclusions drawn from those particular analyses. With a
larger number of studies, data collection would be more
balanced and result in decreased potential for selection bias.
Additionally, a larger sample size would allow for performance
of a meta-regression analysis to ﬁnd the adjusted effect of
each risk factor.
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